BE894563A - Antibiotiques de dioximino-cephalosporines - Google Patents

Antibiotiques de dioximino-cephalosporines

Info

Publication number
BE894563A
BE894563A BE6/47729A BE6047729A BE894563A BE 894563 A BE894563 A BE 894563A BE 6/47729 A BE6/47729 A BE 6/47729A BE 6047729 A BE6047729 A BE 6047729A BE 894563 A BE894563 A BE 894563A
Authority
BE
Belgium
Prior art keywords
dioximino
cephalosporins
antibiotics
cephalosporins antibiotics
Prior art date
Application number
BE6/47729A
Other languages
English (en)
Inventor
W H W Lunn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE894563A publication Critical patent/BE894563A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE6/47729A 1981-10-02 1982-09-30 Antibiotiques de dioximino-cephalosporines BE894563A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/307,983 US4402955A (en) 1981-10-02 1981-10-02 Dioximino cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
BE894563A true BE894563A (fr) 1983-03-30

Family

ID=23192021

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47729A BE894563A (fr) 1981-10-02 1982-09-30 Antibiotiques de dioximino-cephalosporines

Country Status (12)

Country Link
US (1) US4402955A (fr)
JP (1) JPS5869888A (fr)
AU (1) AU8891882A (fr)
BE (1) BE894563A (fr)
DE (1) DE3236065A1 (fr)
FR (1) FR2514004B1 (fr)
GB (1) GB2106905B (fr)
IL (1) IL66888A0 (fr)
IT (1) IT1157330B (fr)
NL (1) NL8203807A (fr)
NZ (1) NZ202034A (fr)
ZA (1) ZA827133B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
EP0053893B1 (fr) * 1980-12-09 1985-03-20 Beecham Group Plc Dérivés de l'acide clavulanique, leur préparation et leur application
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
DE3247614A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
DK2893929T3 (da) 2013-03-15 2025-07-07 Merck Sharp & Dohme Llc Antibiotisk ceftolozansammensætninger
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (fr) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2760484C2 (fr) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
JPS609719B2 (ja) * 1977-08-06 1985-03-12 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
IT1192287B (it) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
GR75644B (fr) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
JPS5869888A (ja) 1983-04-26
ZA827133B (en) 1984-05-30
AU8891882A (en) 1983-04-14
FR2514004A1 (fr) 1983-04-08
NZ202034A (en) 1985-09-13
GB2106905A (en) 1983-04-20
US4402955A (en) 1983-09-06
IL66888A0 (en) 1982-12-31
IT8223566A0 (it) 1982-09-30
GB2106905B (en) 1985-05-15
FR2514004B1 (fr) 1986-04-18
NL8203807A (nl) 1983-05-02
DE3236065A1 (de) 1983-04-14
IT1157330B (it) 1987-02-11

Similar Documents

Publication Publication Date Title
BR8204244A (pt) Pa de aerofolio
DK418085A (da) Antibiotika
BE893795A (fr) Inhalateur-doseur
FI821591L (fi) Loesningsoeverdragningsmetod och -foerfarande
FI823265L (fi) Torkpress
DK95183A (da) Fluidumstroemstyreindretning
AR228298A1 (es) Cubo-rompecabezas
FR2514004B1 (fr) Antibiotiques de dioximino-cephalosporines
FI820806A7 (fi) Kefalosporiiniantibiootteja.
BE889765A (fr) Stijgerelement
ATA518981A (de) Schipaar
FI824536L (fi) Sjaelvhaeftande anslutningsanordning
FI822030A0 (fi) Integrerad oeverbelastningssydskrets
FI822401A0 (fi) Antibakteriella penemderivat
BE893877A (fr) Mond-en tandverzorgingsmiddel
DK282883D0 (da) Braenderhoved
BE894481A (fr) Stromingsmeter
AT384100B (de) Drehrohrofen
BR8206451A (pt) Toca-fitas
BE891918A (fr) Draaibare schoorsteenkap
FR2510990B1 (fr) Alcoylamides de carboxyalcanoylpeptides
BE891837A (fr) Anthracycline-glycosides
SE8205992L (sv) Antibiotika
FR2508080B1 (fr) Construction de lucarne
ATA461081A (de) Hoergeraet

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELI LILLY AND CY

Effective date: 19860930